Search for medicines for human use
Index of medicine substances
Labetalol • Cardiovascular system | Beta blocking agents | Beta blocking agents | Alpha and beta blocking agents (C07AG01)
Lacidipine • Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives (C08CA09)
Lacosamide • Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX18)
Lactic calcium • Alimentary tract and metabolism | Calcium (A12AA05)
Lactobacillus • Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Other antiinfectives and antiseptics (G01AX14)
Lactobacillus acidophilus + estriol • Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Other antiinfectives and antiseptics (G01AX14)
Lactulose • Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Osmotically acting laxatives (A06AD11)
Lamivudine • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors (J05AF05)
Lamivudine + tenofovir disoproxil • Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR12)
Lamivudine + zidovudine • Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR01)
Lamotrigine • Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX09)
Lanadelumab • Blood and blood forming organs | Other hematological agents | Other hematological agents | Drugs used in hereditary angioedema (B06AC05)
Landiolol • Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB14)
Lanreotide • Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues (H01CB03)
Lansoprazole • Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors (A02BC03)
Lanthanum • Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE03)
Lapatinib • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors (L01EH01)
Large bush velvet extract • Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals (G02CX03)
Laronidase • Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB05)
Larotrectinib • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX12)
Latanoprost • Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues (S01EE01)
Latanoprost + netarsudil • Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues (S01EE51)
Latanoprost + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents (S01ED51)
Lauromacrogol 400 • Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection (C05BB02)
Lavender • Nervous system | Anxiolytics | Other anxiolytics (N05BX05)
Lazertinib • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (L01EB09)
Ledipasvir + sofosbuvir • Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections (J05AP51)
Leflunomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA13)
Lenacapavir • Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX31)
Lenalidomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants (L04AX04)